Strategic capital from CVS, Optum, and Elevance is funding the infrastructure to make that viable
Brunkow, S
Studies show that individuals using GLP-1 receptor agonists experience significant weight loss compared to those using traditional methods
however, their effects on OA incidence remain incompletely understood
In rat, mouse and rabbit models without systemic inflammation, the other GLP1-receptor agonists (except exendin-4), dose dependently caused reduced fetal weight and/or growth, retardation of ossification, irregular ossification, and/or skeletal variants such as wavy ribs ( Table 1 )
Venous blood samples were collected in EDTA tubes (BD, NJ, USA) by venipuncture after an overnight fast and prior to the Long COVID evaluation (median follow-up [P25